GRACE Study
Interested in IVF treatment?
If you are a woman between the ages of 18 and 42 who has been diagnosed with infertility (difficulty becoming pregnant), with regular menstrual cycles (every 21-35 days), you may be eligible for participation in this study.
HRC Fertility is currently prescreening participants for the GRACE Study. The trial will be led by Dr. Robert Boostanfar of HRC Fertility’s Valley region, and includes physicians from HRC Fertility Encino locations including Dr. Roy Handelsman, Dr. Alison Peck, and Dr. Irene Woo. The GRACE investigational study is a multicenter, randomized, placebo-controlled, double-blind study to evaluate the efficacy and safety of a human menopausal gonadotropin (hMG) in the development of multiple follicles, pregnancy, and cumulative live birth as part of an assisted reproductive technology (ART) cycle in women undergoing IVF.
Inclusion Criteria:
- Premenopausal women aged 18-42
- BMI ≥18 and < 38 kg/ m²
- Menstrual Cycles between 21-35 days
- AMH > 1.2 ng/ml within 6 months of screening
- Absence of hydrosalpinx
Exclusion Criteria:
- Recurrent implantation failure
- Recurrent pregnancy loss
- Antral follicle Count (AFC) < 5
- Submucosal fibroids or Intramural fibroids ≥ 5cm
- Severe endometriosis (ASRM stage 3 or stage 4)
Other inclusion/exclusion criteria apply please email our study coordinator at clinicaltrialsenc@havingbabies.com
Granata Bio is a biopharma company exclusively focused on identifying and developing innovative therapies that expand access and improve outcomes in reproductive health.
The Investigational study includes up to two IVF stimulations cycles with PGT-A (chromosomes screening of embryos) and, if eligible, up to three frozen embryo transfer (FET) cycles.
For more information on the GRACE Investigational Study the webpage is now live at www.graceivfstudy.com or visit ClinicalTrials.gov listing # NCT07216742.
About HRC Fertility
HRC Fertility is one of the most established providers of advanced IVF and fertility care, with locations across California including Los Angeles, Orange, San Bernardino, San Diego, and the Bay Area, with a Las Vegas location coming soon. For over 35 years, HRC Fertility has remained dedicated to helping hopeful parents preserve their family building options for the future or build families now through world-class assisted reproductive technology, compassion and innovation. For detailed information about HRC Fertility, please see our services, locations, and providers.
About Dr. Robert Boostanfar
Dr. Robert Boostanfar, MD, FACOG is a Board-Certified Reproductive Endocrinologist at HRC Fertility’s Valley region seeing patients at the Valley region’s Encino and Westlake Village locations. Dr. Robert Boostanfar is a leading researcher, and earned his undergraduate degree from the University of California, Los Angeles (UCLA) and graduated medical school from the University of Southern California. He completed his residency in Obstetrics and Gynecology in 1999 and his fellowship in the Division of Reproductive Endocrinology and Infertility in 2002 at the USC Los Angeles County Women’s and Children’s Hospital. Dr. Boostanfar has supported patients across spectrums and has been seen on Good Morning America, CNN, TLC, KTLA, CBS People Magazine and Vogue, in addition to a myriad of nominations and awards.